This episode of The Motley Fool's Market Checkup drills down on the day's hottest headlines and biggest market movers. Market Checkup gives a full examination of a shocking medical device takeover, a hot biotech that can't find an acquirer, a surprise announcement bringing a failed drug, and a big deal in gene sequencing.
In this video, health-care analyst David Williamson discusses Clovis Oncology's failed bid to sell itself. After hanging a for-sale sign on the door, but with no interested parties stepping forward, where does that leave Clovis? Watch and find out along with further details about why its drug pipeline has investors excited.
Looking for more disruptive biotechs?
It's no secret that biotech stocks have been soaring recently, but the best investment strategy is to pick great companies and stick with them for the long term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" not only shares stocks that could help you build long-term wealth, but also winning strategies that every investor should know. Click here to grab your free copy today.